Project Grant K23DK141902
- This $2,482,346 Project Grant was awarded on September 15, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research by the University of Pittsburgh to investigate the role of the ZC3H4 protein and mitochondrial dysfunction in the development of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) in aging men. The research...
- This federal Project Grant award for $390,000 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award aims to study the impact of step therapy utilization management strategies on access to care for patients with overactive bladder (OAB), as well as evaluate alternative patient-centered treatment approaches. Key objectives include using electronic health...
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, awarded a $106,395 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Washington. The grant, running from September 1, 2025 to August 31, 2030, aims to further the development of individuals into future surgeon-scientists engaged in urology research careers. Key objectives include providing medical...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $325,000 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Vivifi Medical, Inc. The grant is for the development of a novel procedure and technology to treat Benign Prostatic Hyperplasia (BPH), the most common ailment for men over 40. The project aims to conduct animal studies to investigate a vascular alteration approach that is expected to naturally...
- This federal Project Grant award of $842,633.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on developing an optimal prehabilitation program for kidney transplant candidates on hemodialysis. The grant aims to elicit expert opinion to identify kidney transplant-specific prehabilitation components and strategies to enhance enrollment and adherence...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $765,701 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The grant, titled "Mapping Mechanosensory Circuits from the Bladder to Barrington's Nucleus," will fund research to explore the neural circuits that encode bladder fullness and control urination. The project...
- This Project Grant award, valued at $199,130.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The objective is to demonstrate the clinical utility of patient-reported outcome measures (PROMs) in the care of individuals with advanced chronic kidney disease (CKD). The award will fund research across two key areas: 1) developing and validating risk...
- The federal Project Grant award of $237,750 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) is supporting a research study to examine nephrology practices' participation decisions and care model reforms under Medicare's Kidney Care Choices payment models. The study, conducted by the Trustees of Indiana University (UEI: SHHBRBAPSM35), aims to better understand how smaller...
- This federal Project Grant award of $737,949 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to modernize clinical methods for assessing fluid excess and removal during in-center hemodialysis treatment. The long-term goal is to improve patient-centered outcomes by leveraging newer techniques like multi-frequency bioelectrical impedance spectroscopy...
This $203,676 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to evaluate patient priorities and the impact of cost on surgical preference for the treatment of benign prostatic hyperplasia (BPH). The key objectives are to: 1) identify the perioperative factors most important to patients undergoing BPH surgical intervention; 2) quantify patient priorities surrounding BPH surgical intervention; and 3) assess the relative importance of cost for patients undergoing BPH surgical intervention. The research methodology involves an ongoing study using validated questionnaires followed by a discrete choice experiment survey to elicit patient preferences. The award has an initial performance period from Aug 1, 2025 to Jul 31, 2028 and is being provided to the Mayo Clinic, a renowned non-profit academic medical center in Minnesota.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $203.7k | 7/24/25 |